BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19008579)

  • 1. Endometrial intraepithelial carcinoma: a case report and brief review.
    Ram M; Bharadwaj M; Yadav R
    Indian J Pathol Microbiol; 2008; 51(4):512-4. PubMed ID: 19008579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
    Zheng W; Liang SX; Yu H; Rutherford T; Chambers SK; Schwartz PE
    Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.
    Liang SX; Chambers SK; Cheng L; Zhang S; Zhou Y; Zheng W
    Int J Surg Pathol; 2004 Oct; 12(4):319-31. PubMed ID: 15494858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma.
    Zheng W; Khurana R; Farahmand S; Wang Y; Zhang ZF; Felix JC
    Am J Surg Pathol; 1998 Dec; 22(12):1463-73. PubMed ID: 9850172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma.
    Tolcher MC; Swisher EM; Medeiros F; Lima JF; Hilderbrand JL; Donovan JL; Garcia RL; Cliby WA; Dowdy SC
    Int J Gynecol Pathol; 2015 Jan; 34(1):57-64. PubMed ID: 25473754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
    Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
    Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.
    Sherman ME; Bur ME; Kurman RJ
    Hum Pathol; 1995 Nov; 26(11):1268-74. PubMed ID: 7590703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLUT1 and p63 expression in endometrial intraepithelial and uterine serous papillary carcinoma.
    Idrees MT; Schlosshauer P; Li G; Burstein DE
    Histopathology; 2006 Jul; 49(1):75-81. PubMed ID: 16842248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.
    Lu B; Chen Q; Zhang X; Cheng L
    Diagn Pathol; 2016 Jun; 11(1):46. PubMed ID: 27260518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation.
    Wheeler DT; Bell KA; Kurman RJ; Sherman ME
    Am J Surg Pathol; 2000 Jun; 24(6):797-806. PubMed ID: 10843281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.
    Ambros RA; Sherman ME; Zahn CM; Bitterman P; Kurman RJ
    Hum Pathol; 1995 Nov; 26(11):1260-7. PubMed ID: 7590702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 expression in endometrial serous carcinomas and its precancers.
    Chen N; Yi X; Abushahin N; Pang S; Zhang D; Kong B; Zheng W
    Int J Clin Exp Pathol; 2010 Dec; 4(1):85-96. PubMed ID: 21228930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma.
    Zheng W; Liang SX; Yi X; Ulukus EC; Davis JR; Chambers SK
    Int J Gynecol Pathol; 2007 Jan; 26(1):38-52. PubMed ID: 17197896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.
    McCluggage WG; Sumathi VP; McManus DT
    Hum Pathol; 2003 Sep; 34(9):939-43. PubMed ID: 14562291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local immune response in serous papillary carcinoma of the endometrium.
    Tamiolakis D; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Jivannakis T; Papadopoulos N
    Histol Histopathol; 2005 Apr; 20(2):403-8. PubMed ID: 15736043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of p53 expression in background endometrium in endometrial carcinoma.
    Nguyen TT; Hachisuga T; Urabe R; Kurita T; Kagami S; Kawagoe T; Shimajiri S; Nabeshima K
    Virchows Arch; 2015 Jun; 466(6):695-702. PubMed ID: 25788166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis.
    Massuger L; Roelofsen T; Ham Mv; Bulten J
    Med Hypotheses; 2010 May; 74(5):859-61. PubMed ID: 20022435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
    Trahan S; TĂȘtu B; Raymond PE
    Hum Pathol; 2005 Dec; 36(12):1316-21. PubMed ID: 16311126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.